Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Elon MuskTweets: 10.3.1 rolling out now

https://twitter.com/elonmusk/status/1452576223620747266?s=20

byCharles Gross

October 25, 2021

1 minute read

10.3.1 rolling out now

— Elon Musk (@elonmusk) October 25, 2021

Jefferies Maintains Hold on Moderna, Lowers Price Target to $325

By Benzinga Newsdesk

November 5, 9:50 AM

Jefferies analyst Michael Yee maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $375 to $325.

MRNA

Lifeist Secures Equity Facility With Alumina Partners And Amends Stock Option Plan

By Vuk Zdinjak

November 16, 11:39 AM

Lifeist Wellness Inc.

NXTTF

Guggenheim Downgrades Palo Alto Networks to Neutral

By Benzinga Newsdesk

January 17, 9:21 AM

Guggenheim analyst John Difucci downgrades Palo Alto Networks (NASDAQ:PANW) from Buy to Neutral.

PANW

Capricor Announces Publication Highlighting New Advances For Its Engineered Exosome Platform

By Benzinga Newsdesk

January 12, 10:29 AM

-StealthX™Exosome Platform Shows Multivalent Vaccine Induces Long-Lasting Immunity to Multiple SARS-CoV-2 Proteins- SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR)

CAPR

Elon MuskTweets: 10.3.1 rolling out now

Related Posts

Jefferies Maintains Hold on Moderna, Lowers Price Target to $325

Lifeist Secures Equity Facility With Alumina Partners And Amends Stock Option Plan

Guggenheim Downgrades Palo Alto Networks to Neutral

Capricor Announces Publication Highlighting New Advances For Its Engineered Exosome Platform